Clinical outcome of transcatheter intervention therapy for combined congenital heart diseases

SONG Zhi-yuan,SHU Mao-qin,HU Hou-yuan,TONG Shi-fei,RAN Bo-li,LIU Jian-ping,LI Yong-hua,HE Guo-xiang

DOI: https://doi.org/10.3321/j.issn:1000-5404.2006.15.026

2014-01-01

Abstract:Objective To probe the safety and clinical results of transcatheter intervention therapy in patients with combined congenital heart deformities.Methods Nineteen patients(9 male and 10 female,aged 4 to 37 years) with combined congenital heart diseases underwent transcatheter intervention therapy.Seven patients were of ventricular septal defect(VSD) and patent ductus arteriosus(PDA),5 patients of VSD and atrial septal defect(ASD),4 of ASD and PDA,2 of ASD and pulmonary stenosis(PS),1 of PDA and congenital coarctation of aorta.The principle of intervention therapy was "the difficulty first then the easy,the complex first then the simple".That is,first balloon valvoplasty of PS was performed,secondly transcatheter closure of VSD,lastly transcatheter closure of PDA or ASD.The electrocardiogram and echocardiography were rechecked at 4 days,1,2,6 and 12 months after intervention therapy during follow-up.Results Transcatheter intervention therapy was successfully performed in all of 19 cases.Two closure devices were implanted in each one of 16 patients.Pulmonary balloon valvoplasty and ASD closure was simultaneously performed in 2 patients,balloon-expandable graft-stent implantation in 1 patient with coarctation of aorta and PDA successfully.Average follow-up period was(15.5±9.4) months(from 3 months to 3 years).No severe complications occurred in follow-up period.Conclusion Combined congenital heart deformities could be simultaneously managed by transcatheter intervention therapy.The indications of intervention therapy should be strictly controlled and the methodology of interventional procedure is skillfully applied.